Q2 2021 Holdings
Filed 2021-08-16 | 8 holdings | $34.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $34.3M | 1,954,904 | 99.8% |
| Natera, Inc.(NTRA) | COM | 632307104 | $14.5K | 127,305 | 0.0% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $13.6K | 108,630 | 0.0% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $8.3K | 998,278 | 0.0% |
| FibroGen, Inc.(FGENEUR) | COM | 31572Q808 | $8.1K | 305,784 | 0.0% |
| Verona Pharma Plc.(VRNA) | SPONSORED ADS | 925050106 | $7.3K | 1,111,112 | 0.0% |
| Cymabay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $7.2K | 1,641,804 | 0.0% |
| Novavax, Inc.(NVAX) | COM | 670002401 | $1.1K | 5,000 | 0.0% |